Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for comfort sedation during tooth extraction
ChiCTR2200064758Phase 4Not yet recruiting
- Sponsor
- The Affiliated Stomatological Hospital of GuangXi Medical University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and midazolam (3 arms), sponsored by The Affiliated Stomatological Hospital of GuangXi Medical University. Primary endpoint: Sedation success rate. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolammidazolam
Beyond the preview
Go deeper on ChiCTR2200064758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064758.